Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Piovesan

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Molecular Genetics & Genomic Medicine|June 26, 2019
Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21Maria Chiara Pelleri, Elena Cicchini, Michael B Petersen, et al.
Physiological Genomics|July 23, 2025
Metabolic and genetic imbalance of the homocysteine-methionine cycle in trisomy 21Beatrice Vione, Bassam Lajin, Francesca Antonaros, et al.
Human Genomics|May 2, 2021
The transcriptome profile of human trisomy 21 blood cellsFrancesca Antonaros, Rossella Zenatelli, Giulia Guerri, et al.
BMC Medical Genomics|December 21, 2022
Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype associationMaria Chiara Pelleri, Chiara Locatelli, Teresa Mattina, et al.
International Journal of Molecular Medicine|April 25, 2019
Analysis of a nanoparticle‑enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesisAlessandro Salvi, Marika Vezzoli, Sara Busatto, et al.
International Journal of Molecular Medicine|June 8, 2019
[Corrigendum] Analysis of a nanoparticle‑enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesisAlessandro Salvi, Marika Vezzoli, Sara Busatto, et al.
Scientific Reports|February 16, 2018
Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolismMaria Caracausi, Veronica Ghini, Chiara Locatelli, et al.
Frontiers in Medicine|December 19, 2022
One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Frontiers in Immunology|May 2, 2024
Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effectGiuseppe Ramacieri, Chiara Locatelli, Michela Semprini, et al.
Frontiers in Medicine|July 3, 2024
Corrigendum: One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Genetics & Genomic Medicine|June 26, 2019
Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21Maria Chiara Pelleri, Elena Cicchini, Michael B Petersen, et al.
Physiological Genomics|July 23, 2025
Metabolic and genetic imbalance of the homocysteine-methionine cycle in trisomy 21Beatrice Vione, Bassam Lajin, Francesca Antonaros, et al.
Human Genomics|May 2, 2021
The transcriptome profile of human trisomy 21 blood cellsFrancesca Antonaros, Rossella Zenatelli, Giulia Guerri, et al.
BMC Medical Genomics|December 21, 2022
Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype associationMaria Chiara Pelleri, Chiara Locatelli, Teresa Mattina, et al.
International Journal of Molecular Medicine|April 25, 2019
Analysis of a nanoparticle‑enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesisAlessandro Salvi, Marika Vezzoli, Sara Busatto, et al.
International Journal of Molecular Medicine|June 8, 2019
[Corrigendum] Analysis of a nanoparticle‑enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesisAlessandro Salvi, Marika Vezzoli, Sara Busatto, et al.
Scientific Reports|February 16, 2018
Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolismMaria Caracausi, Veronica Ghini, Chiara Locatelli, et al.
Frontiers in Medicine|December 19, 2022
One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Frontiers in Immunology|May 2, 2024
Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effectGiuseppe Ramacieri, Chiara Locatelli, Michela Semprini, et al.
Frontiers in Medicine|July 3, 2024
Corrigendum: One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Pageof 5